Preference-weighted HRQoL (utility) ratings are increasingly used to guide clinical and resource allocation decisions, but their performance has not always been adequately explored. We sought to examine patterns of health utility ratings in community populations with depressive disorders and painful conditions.
We used two Canadian cross-sectional health surveys that obtained Comprehensive Health Status Measurement System/Health Utilities Index Mark 3 (HUI3) ratings and identified people with painful conditions and major depression. We estimated the frequency of item endorsements and mean utility ratings in these groups.
Interesting differences between health state ratings and diagnostic categories were noted. For example, 71 % of those professionally diagnosed with migraine reported that they usually have “no pain.” Despite this, utility ratings were lower in those respondents with depressive episodes and in those with painful conditions. Greater than additive reductions in HUI3 scores were noted in most instances where both depressive disorders and painful conditions were present.
Health utility ratings confirm the clinical impression that painful conditions and depressive disorders magnify each other’s impact. Despite weak alignment between the health state definitions incorporated into utility ratings and the diagnostic concepts examined, the HUI3 appeared to capture HRQoL decrements and negative synergies associated with the co-occurrence of depressive episodes and painful conditions.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Brazier, J. (2008). Measuring and valuing mental health for use in economic evaluation. Journal of health services research and policy., 13(Suppl 3), 70–75.
Rabin, R., Oemar, M., Oppe, M., Janssen, B., & Herdman, M. (2011). EQ-5D-5L user guide. Basic Information on How to Use the EQ-5D-5L Instrument.
Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.
American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR).
World Health Organization. (1994). ICD-10 classification of mental and behavioural disorders, with glossary and diagnostic criteria for research.
Zivin, K., McCarthy, J. F., McCammon, R. J., Valenstein, M., Post, E. P., Welsh, D. E., et al. (2008). Health-related quality of life and utilities among patients with depression in the Department of Veterans Affairs. Psychiatric Services (Washington, D. C.), 59(11), 1331–1334.
Egede, L. E. (2007). Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. General Hospital Psychiatry, 29, 409–416.
Patten, S. B., Beck, C. A., Kassam, A., Williams, J. V. A., Barbui, C., & Metz, L. M. (2005). Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Canadian Journal of Psychiatry, 50, 195–202.
Gabilondo, A., Vilagut, G., Pinto-Meza, A., Haro, J. M., & Alonso, J. (2012). Comorbidity of major depressive episode and chronic physical conditions in Spain, a country with low prevalence of depression. General Hospital Psychiatry, 34(5), 510–517.
Egede, L. E., Ellis, C., & Grubaugh, A. L. (2009). The effect of depression on self-care behaviors and quality of care in a national sample of adults with diabetes. General Hospital Psychiatry, 31(5), 422–427.
Stein, M. B., Cox, B. J., Afifi, T. O., Belik, S. L., & Sareen, J. (2006). Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychological Medicine, 36(5), 587–596.
Mohr, D. C., Goodkin, D. E., Likosky, W., Gatto, N., Baumann, K. A., & Rudick, R. A. (1997). Treatment of depression improves adherence to interferon β-1b therapy for multiple sclerosis. Archives of Neurology, 54, 531–533.
Lin, E., Katon, W., Von Korff, M., Tang, L., Williams, J. W., Kroenke, K., et al. (2003). Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA, 290, 2428–2429.
Miller, A. H., Maletic, V., & Raison, C. L. (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65(9), 732–741.
Eisenberger, N. I., Gable, S. L., & Lieberman, M. D. (2007). Functional magnetic resonance imaging responses relate to differences in real-world social experience. Emotion, 7(4), 745–754.
Eisenberger, N. I., Lieberman, M. D., & Williams, K. D. (2003). Does rejection hurt? An FMRI study of social exclusion. Science, 302(5643), 290–292.
Dewall, C. N., Macdonald, G., Webster, G. D., Masten, C. L., Baumeister, R. F., Powell, C., et al. (2010). Acetaminophen reduces social pain: Behavioral and neural evidence. Psychological Science, 21(7), 931–937.
Strigo, I. A., Simmons, A. N., Matthews, S. C., Craig, A. D., & Paulus, M. P. (2008). Increased affective bias revealed using experimental graded heat stimuli in young depressed adults: evidence of “emotional allodynia”. Psychosomatic Medicine, 70(3), 338–344.
Horsman, J., Furlong, W., Feeny, D., & Torrance, G. (2003). The health utilities index (HUI): Concepts, measurement properties and applications. Health Qual Life Outcomes, 1, 54.
Williams, A. (1990). EuroQol—A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.
Ware, J. E, Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.
McHorney, C. A., Ware, J. E, Jr, & Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247–263.
Statistics Canada. (2011). Canadian Community Health Survey—Annual Component (CCHS).
Kessler, R. C., Andrews, G., Mroczek, D., Ustun, B., & Wittchen, H. U. (1998). The world health organization composite international diagnostic interview Short-Form (CIDI-SF). International Journal of Methods in Psychiatric Research, 7, 171–185.
Blazer, D. G., Kessler, R. C., McGonagle, K. A., & Swartz, M. S. (1994). The prevalence and distribution of major depression in a national community sample: The national comorbidity survey. American Journal of Psychiatry, 151, 979–986.
Robins, L. N., Wing, J., Wittchen, H. U., Helzer, J. E., Babor, T. F., Burke, J., et al. (1988). The composite international diagnostic interview. An epidemiological instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry, 45, 1069–1077.
Patten, S. B., Brandon-Christie, J., Devji, J., & Sedmak, B. (2000). Performance of the composite international diagnostic interview short form for major depression in a community sample. Chronic Diseases in Canada, 21, 68–72.
Patten, S. B., Wang, J. L., Williams, J. V., Currie, S., Beck, C. A., Maxwell, C. J., et al. (2006). Descriptive epidemiology of major depression in Canada. Canadian Journal of Psychiatry, 51(2), 84–90.
Gravel, R., & Béland, Y. (2005). The Canadian community health survey: mental health and wellbeing. Canadian Journal of Psychiatry, 50, 573–579.
Centers for Disease Control and Prevention. (2007). The behavioral risk factor surveillance system.
Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., et al. (2003). Screening for serious mental illness in the general population. Archives of General Psychiatry, 60(2), 184–189.
Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z., DePauw, S., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128.
Stata Corporation. (2009). Stata, version 11.0. (11.0).
Vos, T., Haby, M. M., Berendregt, J. J., Kruijshaar, M., Corry, J., & Andrews, G. (2004). The burden of major depression avoidable by longer-term treatment strategies. Archives of General Psychiatry, 61, 1097–1103.
Patten, S. B. (2006). A major depression prognosis calculator based on episode duration. Clinical Practice and Epidemiology in Mental Health, 2, 13.
Patten, S. B. (2008). Major depression prevalence is very high, but the syndrome is a poor proxy for community populations’ clinical treatment needs. Canadian Journal of Psychiatry, 53(7), 411–419.
Kessler, R. C., Andrews, G., Colpe, L. J., Hiripi, E., Mroczek, D. K., & Normand, S. L. (2002). Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine, 32, 959–976.
Feng, Y., Bernier, J., McIntosh, C., & Orpana, H. (2009). Validation of disability categories derived from health utilities index mark 3 scores. Health Reports, 20(2), 43–50.
About this article
Cite this article
Patten, S.B., Williams, J.V.A., Lavorato, D.H. et al. Depression and painful conditions: patterns of association with health status and health utility ratings in the general population. Qual Life Res 23, 363–371 (2014). https://doi.org/10.1007/s11136-013-0449-y
- Health utility
- Health-related quality of life
- Scales, measurement instruments
- Major depression
- Major depressive episode
- Chronic conditions
- Migraine, arthritis, back pain